web analytics
March 7, 2015 / 16 Adar , 5775
At a Glance
InDepth
Sponsored Post


The Israeli Dash to the NASDAQ

Shmuel Zysman

Shmuel Zysman
Photo Credit: Ranit Nachum-Halevi

“The Jewish brain continues to invent new things like it always did,” said Shmuel Zysman, the founder of ZAG-S&W, who was asked to explain the rousing success of Israeli biomed firms listed on the NASDAQ. “There’s tremendous productivity, extraordinary innovation, technological creativity, leadership and management structures that instituted a global vision from day one,” he said. “These are the ingredients for success that we have noticed among our clients.”

“This hasn’t changed, and we always discover a new dimension,” he said. “We saw this in the hi-tech field, and today it’s biotech. There’s no reason to be surprised. There’s something very bold, innovative, and creative in the Israeli mind, and today Israeli biomed is what is happening when it comes to IPOs. There’s no doubt that we are seeing a wonderful year. The numbers are tremendous and they speak for themselves.”

The law firm of ZAG-S&W serves as the model template for a powerhouse Israeli-American firm, with branches in New York, Boston, Washington, Beijing, Shanghai, and Shenzhen. It also has desks in India and Europe. The firm’s clients worldwide receive legal and commercial service 24 hours a day, seven days a week thanks to its team of Israeli, American, and Chinese attorneys. In the U.S. alone, the firm handles over 15 Israeli companies whose shares are traded on the NASDAQ.

“There are a few reasons at the root of the interest in Israeli companies,” Zysman said. “As an international law firm, our investors are usually foreigners as well as people who have a unique familiarity with the field in which they invest. They know exactly what the risk is, and what the reward is, and they wait for Israeli companies to offer their wares.”

“Compared to other foreign biomed companies, the Israeli companies come with a lower price tag,” he said. “If an Israeli company and an American company offered the same product, the American brand would be much more expensive. That is why some of the speculative investors see Israeli firms as having far more potential because the upside is much bigger. Also, Israeli companies have a good reputation. The investors realize this, and they carefully consider every Israeli company that comes in.”

For years now, Israel has become a center for biomed companies. It has enjoyed the benefits of foreign investors who have been attracted by the potential the country offers. Israel has numerous biomed and biotech hubs nestled in industrial parks in Rehovot, Caesarea, Haifa, and Yokneam. Within the next few years, Be’er Sheva is expected to turn into a technological greenhouse in the wake of the ribbon-cutting of the Bionegev Innovation Cluster.

The Israeli biomed community is gradually gaining a reputation worldwide, and it is expected to become a model for others to emulate, just like hi-tech. The success of Israeli companies in the American biomed market stems from all the changes that took shape in the health field in the United States last year. Nonetheless, most of these changes pose new challenges to Israeli firms, requiring them to adjust themselves accordingly with the latest developments.

This will not be an easy undertaking. That is why there are those who believe that the success we have seen recently is indicative of a bubble. To buttress their argument, they point to the triple- and quadruple-digit returns. Ultimately, however, not all of these IPOs will pan out.

“I’m aware of how some analysts are talking in terms of this being a bubble,” Zysman said. “These companies are capable of making tenfold profits of any other company. That is why there is an element of risk versus reward because there is a certain risk that some of these IPOs will ultimately not lead to the desired result, which is an effective, safe drug or a life-saving medical device.”

About the Author: Ranit Nachum-Halevi is a consultant to real estate companies, and former senior real estate correspondent for The Marker, Haaretz's daily financial supplement. She has been working in Israel's media for more than 15 years. You can reach her at ranit.nh@gmail.com.


If you don't see your comment after publishing it, refresh the page.

Our comments section is intended for meaningful responses and debates in a civilized manner. We ask that you respect the fact that we are a religious Jewish website and avoid inappropriate language at all cost.

If you promote any foreign religions, gods or messiahs, lies about Israel, anti-Semitism, or advocate violence (except against terrorists), your permission to comment may be revoked.

No Responses to “The Israeli Dash to the NASDAQ”

Comments are closed.

Current Top Story
Israeli Prime Minister Benjamin Netanyahu addresses a joint meeting of Congress on Capitol Hill in Washington D.C., the United States, calling for rejection of a bad nuclear deal with Iran, on March 03, 2015.
Post-Bibi Bipartisanship May Result in Congressional Ability to Review Iran Deal
Latest Indepth Stories
Ron Prosor

Values at the very heart of the UN are threatened by extremist ideologies targeting our way of life

Ayatollah Ali Khamenei

Anti-Semitism today focuses on Israel and the quest to delegitimize it.

Ballots for elections "made in Samaria."

Any Jew who ties his fate to Israel should be able to vote in Israel’s elections-even before aliyah

A young Moshe Meir Weiss introduces his mother, Mrs. Agnes Weiss Goldman, to Rav Moshe in 1979.

There were no airs about him. Rav Moshe was affectionately known as the Gaon of Normalcy.

Israel’s full sovereignty over a united Jerusalem is the only path for true peace in the region.

Just like Moses and Aaron, Mordechai decides to ruin the party…

The president has made clear – I can’t state this more firmly – the policy is Iran will not get a nuclear weapon.

Obama has an apparent inability to understand Islam in particular and Mid-East culture in general

Pesach is a Torah-based holiday whose fundamental observances are rooted in Torah law; Purim is a rabbinic holiday whose laws and customs are grounded in the rabbinic tradition.

In honor of Prime Minister Netanyahu’s successful speech before Congress.

Mr. Spock conveys a message with painfully stark relevance to our world today, especially in the context of PM Netanyahu’s speech to Congress.

Obama created the “partisan politics” by asking Dem. party members to avoid Bibi and his address

Enough is enough. The Jewish community has a big tent, but the NIF should have no place in it.

I vote for the right and get left-wing policy. Every. Frigging. Time.

More Articles from Ranit Nachum-Halevi
On the beach

Israel’s coastline may be short, but there are still some real estate pearls waiting to be realized, offering cheap alternatives for sea front living. All you have to do is go further from the boundaries of Tel-Aviv and the Dan Block.

Meir Shitrit speaks with the press.

Nave and Golan are advisors helping Meir Sheetrit run for president. As professionals who lead campaigns and shape public opinion, they cite the press as a major factor in this campaign.

Israeli biomedical firms look back on a successful year on Wall Street. Are we bearing witness to “the new tech”?

The romantic skyline of Jerusalem is disappearing. Is Jerusalem on its way to becoming a modern city? Or is it losing its special character?

Government plans to market 12,000 new apartments in Modi’in, where prices haven’t stopped rising in recent years.

It’s a boom: some 100,000 housing units will replace military camps in the high-value center of Israel.

Printed from: http://www.jewishpress.com/indepth/analysis/the-israeli-dash-to-the-nasdaq/2014/05/01/

Scan this QR code to visit this page online: